[1]
Inuzuka T. [Paraneoplastic neurological syndrome--definition and history]. Brain and nerve = Shinkei kenkyu no shinpo. 2010 Apr:62(4):301-8
[PubMed PMID: 20420169]
[2]
Rosenfeld MR, Titulaer MJ, Dalmau J. Paraneoplastic syndromes and autoimmune encephalitis: Five new things. Neurology. Clinical practice. 2012 Sep:2(3):215-223
[PubMed PMID: 23634368]
[3]
Czkwianianc E, Zalewska-Szewczyk B, Kobos J, Socha-Banasiak A, Janczar S, Prymus-Kasińska S, Kazanek-Zasada J, Młynarski W. Uncommon reasons of the digestive tract-related paraneoplastic syndromes in children with neuroblastic tumors: three case reports. Contemporary oncology (Poznan, Poland). 2018:22(1):42-46. doi: 10.5114/wo.2018.74393. Epub 2018 Apr 3
[PubMed PMID: 29692663]
Level 3 (low-level) evidence
[4]
Wu J, Ranjan S. Neoplastic Myelopathies. Continuum (Minneapolis, Minn.). 2018 Apr:24(2, Spinal Cord Disorders):474-496. doi: 10.1212/CON.0000000000000585. Epub
[PubMed PMID: 29613896]
[5]
Popławska-Domaszewicz K, Florczak-Wyspiańska J, Kozubski W, Michalak S. Paraneoplastic movement disorders. Reviews in the neurosciences. 2018 Sep 25:29(7):745-755. doi: 10.1515/revneuro-2017-0081. Epub
[PubMed PMID: 29561731]
[6]
Gapp J, Anwar MF, Parekh J, Griffin T. New onset hyperglycemia attributed to renal cell carcinoma. Intractable & rare diseases research. 2018 May:7(2):134-137. doi: 10.5582/irdr.2018.01034. Epub
[PubMed PMID: 29862157]
[7]
Bhangoo MS, Cheng B, Botta GP, Thorson P, Kosty MP. Reversible intrahepatic cholestasis in metastatic prostate cancer: An uncommon paraneoplastic syndrome. Molecular and clinical oncology. 2018 Apr:8(4):609-612. doi: 10.3892/mco.2018.1564. Epub 2018 Feb 2
[PubMed PMID: 29541472]
[8]
Richa CG, Saad KJ, Halabi GH, Gharios EM, Nasr FL, Merheb MT. Case-series of paraneoplastic Cushing syndrome in small-cell lung cancer. Endocrinology, diabetes & metabolism case reports. 2018:2018():. pii: EDM180004. doi: 10.1530/EDM-18-0004. Epub 2018 Mar 8
[PubMed PMID: 29535866]
Level 3 (low-level) evidence
[9]
Reisch N, Reincke M. [Endocrine paraneoplastic syndromes]. Der Internist. 2018 Feb:59(2):125-133. doi: 10.1007/s00108-017-0377-y. Epub
[PubMed PMID: 29387897]
[10]
Ding JB, Dongas J, Hu K, Ding M. Autoimmune Limbic Encephalitis: A Review of Clinicoradiological Features and the Challenges of Diagnosis. Cureus. 2021 Aug:13(8):e17529. doi: 10.7759/cureus.17529. Epub 2021 Aug 28
[PubMed PMID: 34603897]
[11]
Kubota A, Tajima T, Narukawa S, Yamazato M, Fukaura H, Takahashi Y, Tanaka K, Shimizu J, Nomura K. [Anti-Ma2, anti-NMDA-receptor and anti-GluRε2 limbic encephalitis with testicular seminoma: short-term memory disturbance]. Rinsho shinkeigaku = Clinical neurology. 2012:52(9):666-71
[PubMed PMID: 22989902]
[12]
Inoue T, Kanno R, Moriya A, Nakamura K, Watanabe Y, Matsumura Y, Suzuki H. A Case of Paraneoplastic Limbic Encephalitis in a Patient with Invasive Thymoma with Anti-Glutamate Receptor Antibody-Positive Cerebrospinal Fluid: A Case Report. Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia. 2018 Aug 20:24(4):200-204. doi: 10.5761/atcs.cr.17-00135. Epub 2017 Dec 20
[PubMed PMID: 29269707]
Level 3 (low-level) evidence
[13]
Mauermann ML. Neurologic Complications of Lymphoma, Leukemia, and Paraproteinemias. Continuum (Minneapolis, Minn.). 2017 Jun:23(3, Neurology of Systemic Disease):669-690. doi: 10.1212/CON.0000000000000468. Epub
[PubMed PMID: 28570324]
[14]
Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain : a journal of neurology. 2000 Jul:123 ( Pt 7)():1481-94
[PubMed PMID: 10869059]
[15]
Kobaidze K, Harrison A, Burklin Y, Patidar V, Riccardi M. AUTOIMMUNE LIMBIC ENCEPHALITIS (CASE REPORTS). Georgian medical news. 2017 May:(266):69-74
[PubMed PMID: 28628018]
Level 3 (low-level) evidence
[16]
Collao-Parra JP, Romero-Urra C, Delgado-Derio C. [Autoimmune encephalitis. A review]. Revista medica de Chile. 2018 Mar:146(3):351-361. doi: 10.4067/s0034-98872018000300351. Epub
[PubMed PMID: 29999106]
[17]
Said S, Cooper CJ, Reyna E, Alkhateeb H, Diaz J, Nahleh Z. Paraneoplastic limbic encephalitis, an uncommon presentation of a common cancer: Case report and discussion. The American journal of case reports. 2013:14():391-4. doi: 10.12659/AJCR.889560. Epub 2013 Oct 1
[PubMed PMID: 24116265]
Level 3 (low-level) evidence
[18]
Dalmau J, Graus F. Antibody-Mediated Encephalitis. The New England journal of medicine. 2018 Mar 1:378(9):840-851. doi: 10.1056/NEJMra1708712. Epub
[PubMed PMID: 29490181]
[19]
Dalmau J, Geis C, Graus F. Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System. Physiological reviews. 2017 Apr:97(2):839-887. doi: 10.1152/physrev.00010.2016. Epub
[PubMed PMID: 28298428]
[20]
Ando T, Goto Y, Mano K, Nomura F, Kurashige M, Ito M, Mimuro M, Iwasaki Y, Katsuno M, Yoshida M. Paraneoplastic autoimmune encephalitis associated with pleomorphic lung carcinoma: An autopsy case report. Neuropathology : official journal of the Japanese Society of Neuropathology. 2018 May 20:():. doi: 10.1111/neup.12477. Epub 2018 May 20
[PubMed PMID: 29781194]
Level 3 (low-level) evidence
[21]
Höftberger R, Lassmann H. Immune-mediated disorders. Handbook of clinical neurology. 2017:145():285-299. doi: 10.1016/B978-0-12-802395-2.00020-1. Epub
[PubMed PMID: 28987176]
[22]
Pollak TA, Lennox BR, Müller S, Benros ME, Prüss H, Tebartz van Elst L, Klein H, Steiner J, Frodl T, Bogerts B, Tian L, Groc L, Hasan A, Baune BT, Endres D, Haroon E, Yolken R, Benedetti F, Halaris A, Meyer JH, Stassen H, Leboyer M, Fuchs D, Otto M, Brown DA, Vincent A, Najjar S, Bechter K. Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin. The lancet. Psychiatry. 2020 Jan:7(1):93-108. doi: 10.1016/S2215-0366(19)30290-1. Epub 2019 Oct 24
[PubMed PMID: 31669058]
Level 3 (low-level) evidence
[23]
Nathoo N, Anderson D, Jirsch J. Extreme Delta Brush in Anti-NMDAR Encephalitis Correlates With Poor Functional Outcome and Death. Frontiers in neurology. 2021:12():686521. doi: 10.3389/fneur.2021.686521. Epub 2021 Jul 9
[PubMed PMID: 34305794]
[24]
Hansen N. Long-Term Memory Dysfunction in Limbic Encephalitis. Frontiers in neurology. 2019:10():330. doi: 10.3389/fneur.2019.00330. Epub 2019 Apr 26
[PubMed PMID: 31080433]
[25]
Blattner MS, de Bruin GS, Bucelli RC, Day GS. Sleep disturbances are common in patients with autoimmune encephalitis. Journal of neurology. 2019 Apr:266(4):1007-1015. doi: 10.1007/s00415-019-09230-2. Epub 2019 Feb 11
[PubMed PMID: 30741377]
[26]
Li H, Zhang A, Hao Y, Guan H, Lv Z. Coexistence of Lambert-Eaton myasthenic syndrome and autoimmune encephalitis with anti-CRMP5/CV2 and anti-GABAB receptor antibodies in small cell lung cancer: A case report. Medicine. 2018 May:97(19):e0696. doi: 10.1097/MD.0000000000010696. Epub
[PubMed PMID: 29742721]
Level 3 (low-level) evidence
[27]
Pastuszak Ż, Stępień A, Tomczykiewicz K, Piusińska-Macoch R, Kordowska J, Galbarczyk D, Świstak J. Limbic encephalitis - a report of four cases. Central-European journal of immunology. 2017:42(2):213-217. doi: 10.5114/ceji.2017.69365. Epub 2017 Aug 8
[PubMed PMID: 28860940]
Level 3 (low-level) evidence
[28]
Tsunoda Y, Kiwamoto T, Homma S, Yabuuchi Y, Kitazawa H, Shiozawa T, Nakazawa K, Hosaka T, Ishii K, Ishii A, Tamaoka A, Hizawa N. Paraneoplastic limbic encephalitis with late-onset magnetic resonance imaging findings: A case report. Molecular and clinical oncology. 2017 Aug:7(2):259-262. doi: 10.3892/mco.2017.1311. Epub 2017 Jun 29
[PubMed PMID: 28781798]
Level 3 (low-level) evidence
[29]
Nagafuji H, Yokoi H, Fujiwara M, Sato D, Saito K. Paraneoplastic limbic encephalitis associated with mixed olfactory neuroblastoma and craniopharyngioma: A case report and literature review. Medicine. 2018 Jun:97(24):e10932. doi: 10.1097/MD.0000000000010932. Epub
[PubMed PMID: 29901583]
Level 3 (low-level) evidence
[30]
Rao RM, Chipinapi T, Bharadwaj S, Kissell KA. An unusual case of altered mental status in a young woman. North American journal of medical sciences. 2011 Nov:3(11):518-9. doi: 10.4297/najms.2011.3518. Epub
[PubMed PMID: 22361499]
Level 3 (low-level) evidence
[31]
Schroeder C, Back C, Koc Ü, Strassburger-Krogias K, Reinacher-Schick A, Gold R, Haghikia A. Breakthrough treatment with bortezomib for a patient with anti-NMDAR encephalitis. Clinical neurology and neurosurgery. 2018 Sep:172():24-26. doi: 10.1016/j.clineuro.2018.06.005. Epub 2018 Jun 23
[PubMed PMID: 29960102]
[32]
Scheibe F, Prüss H, Mengel AM, Kohler S, Nümann A, Köhnlein M, Ruprecht K, Alexander T, Hiepe F, Meisel A. Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis. Neurology. 2017 Jan 24:88(4):366-370. doi: 10.1212/WNL.0000000000003536. Epub 2016 Dec 21
[PubMed PMID: 28003505]
[33]
Özkale M, Erol I, Özkale Y, Kozanoğlu İ. Overview of therapeutic plasma exchange in pediatric neurology: a single-center experience. Acta neurologica Belgica. 2018 Sep:118(3):451-458. doi: 10.1007/s13760-018-0961-5. Epub 2018 Jun 7
[PubMed PMID: 29882008]
Level 3 (low-level) evidence
[34]
Yücesan C, Arslan O, Arat M, Yücemen N, Ayyildiz E, Ilhan O, Mutluer N. Therapeutic plasma exchange in the treatment of neuroimmunologic disorders: review of 50 cases. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. 2007 Feb:36(1):103-7
[PubMed PMID: 17224307]
Level 3 (low-level) evidence
[35]
Patel A, Meng Y, Najjar A, Lado F, Najjar S. Autoimmune Encephalitis: A Physician's Guide to the Clinical Spectrum Diagnosis and Management. Brain sciences. 2022 Aug 25:12(9):. doi: 10.3390/brainsci12091130. Epub 2022 Aug 25
[PubMed PMID: 36138865]
[36]
Armangue T, Leypoldt F, Dalmau J. Autoimmune encephalitis as differential diagnosis of infectious encephalitis. Current opinion in neurology. 2014 Jun:27(3):361-8. doi: 10.1097/WCO.0000000000000087. Epub
[PubMed PMID: 24792345]
Level 3 (low-level) evidence
[37]
Attademo L, De Falco S, Rosanova M, Esposito M, Mazio F, Foschini F, Santaniello A, Fiore G, Matano E, Manganelli F, Carlomagno C. A case report of limbic encephalitis in a metastatic colon cancer patient during first-line bevacizumab-combined chemotherapy. Medicine. 2018 Mar:97(9):e0011. doi: 10.1097/MD.0000000000010011. Epub
[PubMed PMID: 29489644]
Level 3 (low-level) evidence
[38]
Shimoyama Y, Umegaki O, Agui T, Kadono N, Minami T. Anti-NMDA receptor encephalitis presenting as an acute psychotic episode misdiagnosed as dissociative disorder: a case report. JA clinical reports. 2016:2(1):22. doi: 10.1186/s40981-016-0048-3. Epub 2016 Sep 1
[PubMed PMID: 29497677]
Level 3 (low-level) evidence
[39]
Shen K, Xu Y, Guan H, Zhong W, Chen M, Zhao J, Li L, Wang M. Paraneoplastic limbic encephalitis associated with lung cancer. Scientific reports. 2018 May 1:8(1):6792. doi: 10.1038/s41598-018-25294-y. Epub 2018 May 1
[PubMed PMID: 29717222]
[40]
Inuzuka T. [Limbic encephalitis: etiology, pathogenesis, diagnosis and therapy]. Rinsho shinkeigaku = Clinical neurology. 2004 Nov:44(11):799-801
[PubMed PMID: 15651295]
[41]
Bloch MH, Hwang WC, Baehring JM, Chambers SK. Paraneoplastic limbic encephalitis: ovarian cancer presenting as an amnesic syndrome. Obstetrics and gynecology. 2004 Nov:104(5 Pt 2):1174-7
[PubMed PMID: 15516442]
[42]
Herman L, Zsigmond IR, Peter L, Rethelyi JM. [Review of the psychiatric aspects of anti-NMDA (N-methyl-D-aspartic acid) receptor encephalitis, case report, and our plans for a future study]. Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology. 2016 Dec:18(4):199-208
[PubMed PMID: 28259863]
Level 3 (low-level) evidence
[43]
van Altena AM, Wijnberg GJ, Kolwijck E, de Hullu JA, Massuger LF. A patient with bilateral immature ovarian teratoma presenting with paraneoplastic encephalitis. Gynecologic oncology. 2008 Feb:108(2):445-8
[PubMed PMID: 18029289]